Suppr超能文献

纤连蛋白III型结构域14在溶液中的结构揭示了其协同肝素结合位点。

The Structure in Solution of Fibronectin Type III Domain 14 Reveals Its Synergistic Heparin Binding Site.

作者信息

Zhong Xueyin, Arnolds Oliver, Krenczyk Oktavian, Gajewski Jana, Pütz Stefanie, Herrmann Christian, Stoll Raphael

机构信息

Ruhr-University of Bochum , Faculty of Chemistry and Biochemistry, Biomolecular NMR , Bochum 44780 , Germany.

Ruhr-University of Bochum , Faculty of Chemistry and Biochemistry, Physical Chemistry I , Bochum 44780 , Germany.

出版信息

Biochemistry. 2018 Oct 23;57(42):6045-6049. doi: 10.1021/acs.biochem.8b00771. Epub 2018 Oct 11.

Abstract

Fibronectin is a large multidomain protein of the extracellular matrix that harbors two heparin binding sites, Hep-I and Hep-II, which support the heparin-dependent adhesion of melanoma and neuroblastoma cells [Barkalow, F. J. B., and Schwarzbauer, J. E. (1991) J. Biol. Chem. 266, 7812-7818; McCarthy, J. B., et al. (1988) Biochemistry 27, 1380-1388; Drake, S. L., et al. (1993) J. Biol. Chem. 268, 15859-15867]. The stronger heparin/HS binding site on fibronectin, Hep-II, spans fibronectin type III domains 12-14. Previous site-directed mutagenesis, nuclear magnetic resonance (NMR) chemical shift perturbation, and crystallographic structural studies all agree that the main heparin binding site is located on the surface of fibronectin type III domain 13 [Ingham, K. C., et al. (1993) Biochemistry 32, 12548-12553; Sharma, A., et al. (1999) EMBO J. 18, 1468-1479; Sachchidanand, L. O., et al. (2002) J. Biol. Chem. 277, 50629-50635]. However, the "synergy site" for heparin binding located on fibronectin type III domain 14 remained elusive because the actual binding sites could not be identified. Using NMR spectroscopy and isothermal titration calorimetry, we show here that heparin is able to bind to a cationic 'cradle' of fibronectin type III domain 14 formed by the PRARI sequence, which is involved in the integrin αβ interaction [Mould, A. P., and Humphries, M. J. (1991) EMBO J. 10, 4089-4095], and to the flexible loop comprising residues KNNQKSE between the last two β-strands, D and E, of FN14. Our data reveal that the individual FN14 domain binds to the sulfated sugars Dp8 and Reviparin with affinities similar to those of the individual domain FN13 [Breddin, H. K. (2002) Expert Opin. Pharmacother. 3, 173-182]. It is noteworthy that by introduction of the last β-strand of FN13 and the linker region between FN type III domains 13 and 14, the perturbation of NMR chemical shifts by heparin is significantly reduced, especially at the PRARI site. This indicates that the Hep-II binding site of fibronectin is mainly located on FN13 and the synergistic binding site on FN14 involves only the KNNQKSE sequence.

摘要

纤连蛋白是细胞外基质中的一种大型多结构域蛋白,含有两个肝素结合位点,即Hep-I和Hep-II,它们支持黑色素瘤细胞和神经母细胞瘤细胞的肝素依赖性黏附[Barkalow, F. J. B., and Schwarzbauer, J. E. (1991) J. Biol. Chem. 266, 7812 - 7818; McCarthy, J. B., et al. (1988) Biochemistry 27, 1380 - 1388; Drake, S. L., et al. (1993) J. Biol. Chem. 268, 15859 - 15867]。纤连蛋白上更强的肝素/硫酸乙酰肝素结合位点Hep-II跨越纤连蛋白III型结构域12 - 14。先前的定点诱变、核磁共振(NMR)化学位移扰动和晶体学结构研究均一致认为,主要的肝素结合位点位于纤连蛋白III型结构域13的表面[Ingham, K. C., et al. (1993) Biochemistry 32, 12548 - 12553; Sharma, A., et al. (1999) EMBO J. 18, 1468 - 1479; Sachchidanand, L. O., et al. (2002) J. Biol. Chem. 277, 50629 - 50635]。然而,位于纤连蛋白III型结构域14上的肝素结合“协同位点”仍然难以捉摸,因为实际的结合位点无法确定。通过核磁共振光谱和等温滴定量热法,我们在此表明肝素能够结合到由PRARI序列形成的纤连蛋白III型结构域14的阳离子“摇篮”上,该序列参与整合素αβ相互作用[Mould, A. P., and Humphries, M. J. (1991) EMBO J. 10, 4089 - 4095],并结合到FN14的最后两条β链D和E之间包含残基KNNQKSE的柔性环上。我们的数据表明,单个FN14结构域与硫酸化糖Dp8和瑞伐肝素的结合亲和力与单个结构域FN13相似[Breddin, H. K. (2002) Expert Opin. Pharmacother. 3, 可见,通过引入FN13的最后一条β链以及FN III型结构域13和14之间的连接区域,肝素对NMR化学位移的扰动显著降低,尤其是在PRARI位点。这表明纤连蛋白的Hep-II结合位点主要位于FN13上,而FN14上的协同结合位点仅涉及KNNQKSE序列。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验